Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.45% | 185.15 | 1.2% | $602.67m | |
| CELG | Celgene Corporation | -0.43% | 78.80 | 1.2% | $532.62m | |
| GILD | Gilead Sciences, Inc. | -0.63% | 71.07 | 0.9% | $518.63m | |
| BIIB | Biogen Inc. | -0.44% | 296.04 | 1.2% | $437.32m | |
| NKTR | Nektar Therapeutics | -5.39% | 52.85 | 5.6% | $412.99m | |
| SRPT | Sarepta Therapeutics, Inc. | -6.23% | 140.33 | 16.6% | $356.37m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.67% | 159.19 | 1.9% | $269.27m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.89% | 331.97 | 2.6% | $248.01m | |
| ILMN | Illumina, Inc. | -1.19% | 282.65 | 3.5% | $212.82m | |
| BLUE | Bluebird Bio, Inc. | -9.85% | 168.90 | 15.7% | $194.29m | |
| EXAS | Exact Sciences Corporation | -3.62% | 66.33 | 25.4% | $180.98m | |
| A | Agilent Technologies, Inc. | -0.40% | 62.79 | 1.5% | $178.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.40% | 127.57 | 2.0% | $159.93m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.61% | 99.03 | 4.4% | $141.99m | |
| INCY | Incyte Corporation | 2.12% | 74.03 | 2.5% | $133.28m |
Company Profile
Mirati Therapeutics, Inc. is a clinical-stage oncology company, which engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.